Transgenic cattle constitute a breakthrough in production of innovative medicine. From milk to medicine

The continuously increasing demand for biomolecules, e.g. human proteins, for applications in human health care, is one of the main driving forces for the development of safe, large-scale production systems. One very promising approach is the production of biomolecules in the milk of transgenic cattle. By using nuclear transfer technology, transgenic cattle can be generated in a very safe and efficient manner, thereby offering a significant time reduction when compared to conventional breeding methods. As a result, that the transgenic cattle platform offers an efficient, safe and cost-effective method for producing large amounts of biopharmaceuticals, which is essential to the development of innovative health care products.